JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Healthcare | 9.65% |
| 3 | Financials | 9.27% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
Janux Therapeutics
JANX
$986M
| $190K | ﹤0.01% |
17,736
-130,873
| -88% | -$1.13M |
|
5177
Accuray
ARAY
$33.2M
| $190K | ﹤0.01% |
67,225
+3,836
| +6% | +$10.5K |
|
5178
Organogenesis Holdings
ORGO
$230M
| $190K | ﹤0.01% |
46,464
-1,582
| -3% | -$4.43K |
|
5179
ARS Pharmaceuticals
SPRY
$562M
| $190K | ﹤0.01% |
34,649
+369
| +1% | +$1.62K |
|
5180
Park Aerospace
PKE
$831M
| $190K | ﹤0.01% |
12,907
-305
| -2% | -$4.56K |
|
5181
LCNB Corp
LCNB
$283M
| $190K | ﹤0.01% |
12,027
+5,167
| +75% | +$76K |
|
5182
CALL
Starwood Property Trust
STWD
$6.03B
| $189K | ﹤0.01% |
+9,000
| New | +$177K |
|
5183
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.42B
| $189K | ﹤0.01% |
1,809
+3
| +0.2% | +$281 |
|
5184
The ONE Group
STKS
$57.8M
| $189K | ﹤0.01% |
30,835
+11,128
| +56% | +$55.1K |
|
5185
Chemung Financial Corp
CHMG
$405M
| $188K | ﹤0.01% |
3,782
+999
| +36% | +$44.3K |
|
|
DOO
5186
Bombardier Recreational Products
DOO
$4.73B
| $188K | ﹤0.01% |
2,619
-6,057
| -70% | -$424K |
|
5187
Willis Lease Finance
WLFC
$1.2B
| $187K | ﹤0.01% |
11,460
+5,199
| +83% | +$77.3K |
|
5188
Rigel Pharmaceuticals
RIGL
$795M
| $186K | ﹤0.01% |
12,822
-8,583
| -40% | -$87.8K |
|
5189
Hooker Furnishings Corp
HOFT
$158M
| $185K | ﹤0.01% |
7,104
-59
| -0.8% | -$1.18K |
|
5190
Erasca
ERAS
$6.43B
| $185K | ﹤0.01% |
86,835
+4,726
| +6% | +$9.97K |
|
5191
C&F Financial
CFFI
$287M
| $185K | ﹤0.01% |
2,712
+583
| +27% | +$34K |
|
|
PBPB
5192
DELISTED
Potbelly
PBPB
| $185K | ﹤0.01% |
17,739
| – | – |
|
5193
Simplify Multi-QIS Alternative ETF
QIS
$39.7M
| $184K | ﹤0.01% |
+7,454
| New | +$191K |
|
5194
Axogen
AXGN
$2.62B
| $184K | ﹤0.01% |
26,897
-914
| -3% | -$5.08K |
|
5195
Spok Holdings
SPOK
$229M
| $183K | ﹤0.01% |
11,837
-268
| -2% | -$4.12K |
|
|
MIN
5196
Aberdeen Intermediate Income Fund
MIN
$282M
| $183K | ﹤0.01% |
68,341
+63,750
| +1,389% | +$170K |
|
|
MRSN
5197
DELISTED
Mersana Therapeutics
MRSN
| $183K | ﹤0.01% |
3,153
-7,528
| -70% | -$303K |
|
|
BCYC
5198
Bicycle Therapeutics
BCYC
$273M
| $183K | ﹤0.01% |
10,106
-58,393
| -85% | -$966K |
|
|
MITT
5199
TPG Mortgage Investment Trust
MITT
$215M
| $182K | ﹤0.01% |
28,705
+28,680
| +114,720% | +$156K |
|
5200
Latham Group
SWIM
$861M
| $182K | ﹤0.01% |
69,243
-8,268
| -11% | -$20.5K |
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.